SEC Form 4 · accession 0001209191-16-146408
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henry A McKinnell
Director
Period of report
Oct 17, 2016
Accepted (ET)
Oct 19, 2016 · 7:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Oct 17, 2016 | A | 30,120 | A | — | — | Common Stock | 30,120 | 30,120 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
- F2The restricted stock units were awarded on October 17, 2017 and vest in three equal installments on October 17, 2017, October 17, 2018 and October 17, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer through each such vesting date. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.